Church & Dwight Reports Q3 2022 Results
Church & Dwight Co., Inc. (NYSE: CHD) reported a 0.4% increase in third quarter net sales, reaching $1,317.3 million, despite a 1% drag from currency. Organic sales declined 0.7% due to an 8.5% drop in volume, somewhat balanced by a 7.8% rise in pricing. The EPS fell 17.4% year-over-year to $0.76. Full year net sales growth is projected at 3% with organic growth at 1%. The company's recent acquisition of Hero brands is expected to enhance market presence.
- Q3 net sales beat expectations with a 0.4% increase.
- U.S. portfolio saw consumption growth in 11 out of 17 categories.
- ARM & HAMMER brand achieved all-time high market shares.
- International organic sales grew 3.2%.
- Recent acquisition of Hero brand expected to drive further growth.
- Organic sales declined 0.7% due to an 8.5% drop in volume.
- Discretionary brands like Waterpik and Flawless saw decreased consumer spending.
- Gross margin contracted by 250 bps due to rising costs.
- Full year adjusted EPS expected to decline by 2-3%.
2022 Third Quarter Results
-
Net Sales +0.4% : Domestic +1.2% , Int’l -3.2 %, SPD +1.0% -
Organic sales -
0.7% : Domestic -1.7% , Int’l +3.2% , SPD +1.0% -
EPS
, -$0.76 5% vs prior year Adjusted EPS1
2022 Full Year Outlook
-
Net Sales growth +3% ; Organic Sales +1% 1 -
Reported EPS -
13% to -11% , Adjusted EPS -3% to -2% 1 -
Cash from operations
~ $800 million
Third quarter 2022 EPS was
“In Q3, our most discretionary brands (Waterpik and Flawless) were impacted by lower consumer spending and account for approximately
“Our International business reported organic sales growth of
“In our Specialty Products business, organic sales grew
“Gross margin contracted 250 bps reflecting higher commodities and third-party manufacturing costs as well as higher promotional spending. Looking forward, we will continue to pursue additional measures to offset these higher costs including pricing, productivity and pack size changes.
“Our recent acquisitions are performing well, with THERABREATH™ experiencing double-digit consumption growth in the quarter and both ZICAM™ and THERABREATH™ gaining share.
“In mid-October, we closed our most recent acquisition of the Hero Mighty Patch® brand (Hero) and other acne treatment products. Hero is the #2 brand in the acne treatment category in
Third Quarter Review
Consumer Domestic net sales were
Specialty Products net sales were
Gross margin decreased 250 basis points to
Marketing expense was
Selling, general, and administrative expense (SG&A) was
Income from Operations was
Other Expense of
The effective tax rate decreased to
Operating Cash Flow
For the first nine months of 2022, cash from operating activities was
Capital expenditures for the first nine months were
On
Outlook for 2022
“Now that fill level recovery has improved, we will continue to invest incrementally in marketing behind our brands in Q4 to ensure long term growth.
“We now expect adjusted EPS to be in the range of
1 See non-GAAP reporting reconciliations included at the end of this release.
2 The Q4 adjusted EPS will exclude the impact of charges related to the restricted stock that was issued for the Hero acquisition, which will be treated as compensation. This charge is estimated to negatively impact reported EPS by
For more information, see the
This press release contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; the impact of the COVID-19 pandemic and the Company’s response; gross margin changes; trade, marketing, and SG&A spending; sufficiency of cash flows from operations; earnings per share; cost savings programs; recessionary conditions; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of acquisitions (including earn-outs); and capital expenditures. Other forward-looking statements in this release may be identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); including those relating to the outbreak of contagious diseases; other impacts of the COVID-19 pandemic and its impact on the Company’s operations, customers, suppliers, employees, and other constituents, and market volatility and impact on the economy (including causing recessionary conditions), resulting from global, nationwide or local or regional outbreaks or increases in infections, new variants, and the risk that the Company will not be able to successfully execute its response plans with respect to the pandemic or localized outbreaks and the corresponding uncertainty; the impact of regulatory changes or policies associated with the COVID-19 pandemic, including continuing or renewed shutdowns of retail and other businesses in various jurisdictions; the impact on the global economy of the military conflict between
For a description of additional factors that could cause actual results to differ materially from the forward-looking statements, please see Item 1A, “Risk Factors” in the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the
This press release also contains non-GAAP financial information. Management uses this information in its internal analysis of results and believes that this information may be informative to investors in gauging the quality of the Company’s financial performance, identifying trends in its results and providing meaningful period-to-period comparisons. The Company has included reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP. See the end of this press release for these reconciliations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read in connection with the Company’s financial statements presented in accordance with GAAP.
|
||||||||||||||||
Condensed Consolidated Statements of Income (Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
(In millions, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
$ |
1,317.3 |
|
|
$ |
1,311.4 |
|
|
$ |
3,939.6 |
|
|
$ |
3,821.4 |
|
Cost of sales |
|
|
767.6 |
|
|
|
732.2 |
|
|
|
2,292.1 |
|
|
|
2,139.1 |
|
Gross Profit |
|
|
549.7 |
|
|
|
579.2 |
|
|
|
1,647.5 |
|
|
|
1,682.3 |
|
Marketing expenses |
|
|
140.7 |
|
|
|
160.9 |
|
|
|
345.5 |
|
|
|
376.6 |
|
Selling, general and administrative expenses |
|
|
155.1 |
|
|
|
116.9 |
|
|
|
505.8 |
|
|
|
403.0 |
|
Income from Operations |
|
|
253.9 |
|
|
|
301.4 |
|
|
|
796.2 |
|
|
|
902.7 |
|
Equity in earnings of affiliates |
|
|
3.7 |
|
|
|
2.0 |
|
|
|
10.0 |
|
|
|
7.4 |
|
Other income (expense), net |
|
|
(23.1 |
) |
|
|
(14.1 |
) |
|
|
(59.0 |
) |
|
|
(42.5 |
) |
Income before Income Taxes |
|
|
234.5 |
|
|
|
289.3 |
|
|
|
747.2 |
|
|
|
867.6 |
|
Income taxes |
|
|
47.4 |
|
|
|
58.9 |
|
|
|
168.6 |
|
|
|
198.2 |
|
Net Income |
|
$ |
187.1 |
|
|
$ |
230.4 |
|
|
$ |
578.6 |
|
|
$ |
669.4 |
|
Net Income per share - Basic |
|
$ |
0.77 |
|
|
$ |
0.94 |
|
|
$ |
2.38 |
|
|
$ |
2.73 |
|
Net Income per share - Diluted |
|
$ |
0.76 |
|
|
$ |
0.92 |
|
|
$ |
2.35 |
|
|
$ |
2.68 |
|
Dividends per share |
|
$ |
0.26 |
|
|
$ |
0.25 |
|
|
$ |
0.79 |
|
|
$ |
0.76 |
|
Weighted average shares outstanding - Basic |
|
|
242.8 |
|
|
|
245.3 |
|
|
|
242.7 |
|
|
|
245.2 |
|
Weighted average shares outstanding - Diluted |
|
|
246.0 |
|
|
|
249.8 |
|
|
|
246.4 |
|
|
|
249.9 |
|
|
|||||||
Condensed Consolidated Balance Sheets (Unaudited) |
|||||||
(Dollars in millions) |
|
|
|
|
|
||
Assets |
|
|
|
|
|
||
Current Assets |
|
|
|
|
|
||
Cash and Cash Equivalents |
|
$ |
437.6 |
|
|
$ |
240.6 |
Accounts Receivable |
|
|
391.3 |
|
|
|
405.5 |
Inventories |
|
|
675.3 |
|
|
|
535.4 |
Other Current Assets |
|
|
60.2 |
|
|
|
51.9 |
Total Current Assets |
|
|
1,564.4 |
|
|
|
1,233.4 |
Property, Plant and Equipment (Net) |
|
|
716.3 |
|
|
|
652.7 |
|
|
|
11.9 |
|
|
|
9.1 |
|
|
|
3,404.1 |
|
|
|
3,494.3 |
|
|
|
2,270.7 |
|
|
|
2,274.5 |
Other Long-Term Assets |
|
|
320.4 |
|
|
|
332.5 |
Total Assets |
|
$ |
8,287.8 |
|
|
$ |
7,996.5 |
Liabilities and Stockholders’ Equity |
|
|
|
|
|
||
Short-Term Debt |
|
$ |
3.3 |
|
|
$ |
252.8 |
Current portion of Long-Term debt |
|
|
400.0 |
|
|
|
699.4 |
Other Current Liabilities |
|
|
1,047.3 |
|
|
|
1,123.0 |
Total Current Liabilities |
|
|
1,450.6 |
|
|
|
2,075.2 |
Long-Term Debt |
|
|
2,104.4 |
|
|
|
1,610.7 |
Other Long-Term Liabilities |
|
|
1,045.0 |
|
|
|
1,077.4 |
Stockholders’ Equity |
|
|
3,687.8 |
|
|
|
3,233.2 |
Total Liabilities and Stockholders’ Equity |
|
$ |
8,287.8 |
|
|
$ |
7,996.5 |
|
||||||||
Condensed Consolidated Statements of Cash Flow (Unaudited) |
||||||||
|
|
Nine Months Ended |
|
|||||
(Dollars in millions) |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Net Income |
|
$ |
578.6 |
|
|
$ |
669.4 |
|
|
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
160.6 |
|
|
|
164.9 |
|
Change in fair value of business acquisition liabilities |
|
|
- |
|
|
|
(98.0 |
) |
Deferred income taxes |
|
|
(12.7 |
) |
|
|
32.8 |
|
Non-cash compensation |
|
|
22.0 |
|
|
|
20.3 |
|
Other |
|
|
(4.3 |
) |
|
|
5.9 |
|
Subtotal |
|
|
744.2 |
|
|
|
795.3 |
|
|
|
|
|
|
|
|
||
Changes in assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable |
|
|
(1.7 |
) |
|
|
(12.0 |
) |
Inventories |
|
|
(152.7 |
) |
|
|
(59.9 |
) |
Other current assets |
|
|
4.7 |
|
|
|
6.1 |
|
Accounts payable and accrued expenses |
|
|
(56.0 |
) |
|
|
(50.8 |
) |
Income taxes payable |
|
|
16.5 |
|
|
|
(10.3 |
) |
Other |
|
|
(20.9 |
) |
|
|
(14.8 |
) |
Net cash from operating activities |
|
|
534.1 |
|
|
|
653.6 |
|
|
|
|
|
|
|
|
||
Capital expenditures |
|
|
(98.1 |
) |
|
|
(64.1 |
) |
Other |
|
|
(2.6 |
) |
|
|
(5.6 |
) |
Net cash (used in) investing activities |
|
|
(100.7 |
) |
|
|
(69.7 |
) |
|
|
|
|
|
|
|
||
Net change in long-term debt |
|
|
199.8 |
|
|
|
(300.0 |
) |
Net change in short-term debt |
|
|
(249.5 |
) |
|
|
(71.6 |
) |
Payment of cash dividends |
|
|
(191.2 |
) |
|
|
(185.8 |
) |
Proceeds from stock option exercises |
|
|
22.4 |
|
|
|
26.9 |
|
Purchase of treasury stock |
|
|
- |
|
|
|
(54.9 |
) |
Deferred financing and other |
|
|
(7.5 |
) |
|
|
- |
|
Net cash (used in) financing activities |
|
|
(226.0 |
) |
|
|
(585.4 |
) |
|
|
|
|
|
|
|
||
F/X impact on cash |
|
|
(10.4 |
) |
|
|
(1.6 |
) |
|
|
|
|
|
|
|
||
Net change in cash and cash equivalents |
|
$ |
197.0 |
|
|
$ |
(3.1 |
) |
2022 and 2021 Product |
|||||||||||
|
Three Months Ended |
|
|
Percent |
|
||||||
|
|
|
|
|
|
|
Change |
|
|||
Household Products |
$ |
592.3 |
|
|
$ |
535.5 |
|
|
|
10.6 |
% |
Personal Care Products |
|
418.1 |
|
|
|
462.6 |
|
|
|
-9.6 |
% |
Consumer Domestic |
$ |
1,010.4 |
|
|
$ |
998.1 |
|
|
|
1.2 |
% |
|
|
219.7 |
|
|
|
227.0 |
|
|
|
-3.2 |
% |
Total Consumer |
$ |
1,230.1 |
|
|
$ |
1,225.1 |
|
|
|
0.4 |
% |
Specialty Products Division |
|
87.2 |
|
|
|
86.3 |
|
|
|
1.0 |
% |
Total |
$ |
1,317.3 |
|
|
$ |
1,311.4 |
|
|
|
0.4 |
% |
|
|
|
|
|
|
|
|
|
|||
|
Nine Months Ended |
|
|
Percent |
|
||||||
|
|
|
|
|
|
|
Change |
|
|||
Household Products |
$ |
1,685.6 |
|
|
$ |
1,553.7 |
|
|
|
8.5 |
% |
Personal Care Products |
|
1,324.6 |
|
|
|
1,346.5 |
|
|
|
-1.6 |
% |
Consumer Domestic |
$ |
3,010.2 |
|
|
$ |
2,900.2 |
|
|
|
3.8 |
% |
|
|
664.8 |
|
|
|
670.2 |
|
|
|
-0.8 |
% |
Total Consumer |
$ |
3,675.0 |
|
|
$ |
3,570.4 |
|
|
|
2.9 |
% |
Specialty Products Division |
|
264.6 |
|
|
|
251.0 |
|
|
|
5.4 |
% |
Total |
$ |
3,939.6 |
|
|
$ |
3,821.4 |
|
|
|
3.1 |
% |
Non-GAAP Measures:
The following discussion addresses the non-GAAP measures used in this press release and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures. These non-GAAP financial measures should not be considered in isolation from or as a substitute for the comparable GAAP measures. The following non-GAAP measures may not be the same as similar measures provided by other companies due to differences in methods of calculation and items and events being excluded.
Organic Sales Growth:
This press release provides information regarding organic sales growth, namely net sales growth excluding the effect of acquisitions, divestitures and foreign exchange rate changes. Management believes that the presentation of organic sales growth is useful to investors because it enables them to assess, on a consistent basis, sales trends related to products that were marketed by the Company during the entirety of relevant periods, excluding the impact of acquisitions, divestitures, and foreign exchange rate changes that are out of the control of, and do not reflect the performance of the Company and management.
Adjusted Selling, General, and Administrative Expense (SG&A):
This press release also presents adjusted SG&A, namely, SG&A calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year SG&A expense.
Adjusted Income from Operations:
This press release also presents adjusted income from operations, namely income from operations calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year income from operations.
Adjusted EPS:
This press release also presents adjusted earnings per share, namely, EPS calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year EPS growth.
|
|||||||||
Organic Sales |
|||||||||
|
|||||||||
|
Three Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
Total |
|
Worldwide |
|
Consumer |
|
Consumer |
|
Specialty |
|
Company |
|
Consumer |
|
Domestic |
|
International |
|
Products |
Reported Sales Growth |
|
|
|
|
|
|
- |
|
|
Less: |
|
|
|
|
|
|
|
|
|
Acquisitions |
|
|
|
|
|
|
|
|
|
Add: |
|
|
|
|
|
|
|
|
|
FX / Other |
|
|
|
|
|
|
|
|
|
Divestitures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic Sales Growth |
- |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
Total |
|
Worldwide |
|
Consumer |
|
Consumer |
|
Specialty |
|
Company |
|
Consumer |
|
Domestic |
|
International |
|
Products |
Reported Sales Growth |
|
|
|
|
|
|
- |
|
|
Less: |
|
|
|
|
|
|
|
|
|
Acquisitions |
|
|
|
|
|
|
|
|
|
Add: |
|
|
|
|
|
|
|
|
|
FX / Other |
|
|
|
|
|
|
|
|
|
Divestitures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic Sales Growth |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Reconciliation of GAAP Measures to Non-GAAP Measures (Unaudited) |
||||||||||||||||||||
(Dollars in millions, except per share data) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
For the quarter ended
|
|
|
For the quarter ended
|
|
|
Change |
|||||||||||||
|
|
|
|
% of NS |
|
|
|
|
|
% of NS |
|
|
|
|
|
|||||
Adjusted SG&A Reconciliation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
SG&A - Reported |
$ |
155.1 |
|
|
|
11.7 |
% |
|
$ |
116.9 |
|
|
|
8.9 |
% |
|
|
280 |
|
bps |
Flawless Earn-Out Adjustment |
|
- |
|
|
|
0.0 |
% |
|
|
41.0 |
|
|
|
3.1 |
% |
|
|
-310 |
|
bps |
SG&A - Adjusted (non-GAAP) |
$ |
155.1 |
|
|
|
11.7 |
% |
|
$ |
157.9 |
|
|
|
12.0 |
% |
|
|
-30 |
|
bps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
For the quarter ended
|
|
|
For the quarter ended
|
|
|
Change |
|||||||||||||
Adjusted Income From Operations |
|
|
|
% of NS |
|
|
|
|
|
% of NS |
|
|
|
|
|
|||||
Income From Operations - Reported |
$ |
253.9 |
|
|
|
19.3 |
% |
|
$ |
301.4 |
|
|
|
23.0 |
% |
|
|
-370 |
|
bps |
Flawless Earn-Out Adjustment |
|
- |
|
|
|
0.0 |
% |
|
|
-41.0 |
|
|
|
-3.1 |
% |
|
|
310 |
|
bps |
Income From Operations - Adjusted (non-GAAP) |
$ |
253.9 |
|
|
|
19.3 |
% |
|
$ |
260.4 |
|
|
|
19.9 |
% |
|
|
-60 |
|
bps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
For the quarter ended
|
|
|
For the quarter ended
|
|
|
Change |
|||||||||||||
Adjusted Diluted Earnings Per Share Reconciliation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Diluted Earnings Per Share - Reported |
$ |
0.76 |
|
|
|
|
|
$ |
0.92 |
|
|
|
|
|
|
-17.4 |
% |
|
||
Flawless Earn-Out Adjustment |
|
- |
|
|
|
|
|
|
-0.12 |
|
|
|
|
|
|
|
|
|||
Diluted Earnings Per Share - Adjusted (non-GAAP) |
$ |
0.76 |
|
|
|
|
|
$ |
0.80 |
|
|
|
|
|
|
-5.0 |
% |
|
Reported and Organic Forecasted Sales Reconciliation |
|||
|
|
|
|
|
For the Quarter |
|
For the Year |
|
Ended |
|
Ended |
|
|
|
|
Reported Sales Growth |
|
|
|
Less: Acquisition |
- |
|
- |
Add: FX / Other |
|
|
|
|
|
|
|
Organic Sales Growth |
- |
|
|
|
For the quarter ended
|
|
For the quarter ended
|
|
Change |
Adjusted Diluted Earnings Per Share Reconciliation (Forecasted) |
|
|
|
|
|
Diluted Earnings Per Share - Reported |
|
|
|
|
- |
Hero Acquisition Restricted Stock Expense |
0.03 |
|
- |
|
|
Diluted Earnings Per Share - Adjusted (non-GAAP) |
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended
|
|
For the year ended
|
|
Change |
Adjusted Diluted Earnings Per Share Reconciliation (Forecasted) |
|
|
|
|
|
Diluted Earnings Per Share - Reported |
|
|
|
|
- |
Hero Acquisition Restricted Stock Expense |
0.03 |
|
- |
|
|
Flawless Earn-Out Adjustment |
- |
|
(0.30) |
|
|
Diluted Earnings Per Share - Adjusted (non-GAAP) |
|
|
|
|
- |
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221028005104/en/
Chief Financial Officer
609-806-1200
Source:
FAQ
What were the net sales for Church & Dwight in Q3 2022?
How did Church & Dwight's EPS change in Q3 2022?
What is the full-year sales growth outlook for Church & Dwight in 2022?
What factors contributed to the decline in organic sales for Church & Dwight?